Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George M Shaw

Showing results (41-50 of 242) with videos related to

Pageof 25
Sort By:
Mbio|February 26, 2015
Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liverAngela M Mitchell, Amy E L Stone, Linling Cheng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2018
Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistenceRuian Ke, Hui Li, Shuyi Wang, et al.
Plos One|July 16, 2020
Assessing routes of hepatitis C transmission in HIV-infected men who have sex with men using single genome sequencingHui Li, Kristen M Marks, Andrew H Talal, et al.
Journal of Molecular Biology|July 16, 2008
Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoproteinFrançois Stricher, Chih-chin Huang, Anne Descours, et al.
Journal of Virology|April 6, 2007
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donorsAmandeep K Dhillon, Helen Donners, Ralph Pantophlet, et al.
Journal of Virology|March 8, 2013
Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stockMichael Lopker, Juliet Easlick, Sarah Sterrett, et al.
Immunity|January 3, 2024
Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infectionNicole Frumento, Ariadne Sinnis-Bourozikas, Harry T Paul, et al.
Journal of Virology|July 26, 2022
Correction for Rudicell et al., "High Prevalence of Simian Immunodeficiency Virus Infection in a Community of Savanna Chimpanzees"Rebecca S Rudicell, Alex K Piel, Fiona Stewart, et al.
Journal of Virology|November 21, 2008
Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasmaKatie L Davis, Frederic Bibollet-Ruche, Hui Li, et al.
Nature Medicine|February 1, 2002
Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cellsGang Meng, Xiping Wei, Xiaoyun Wu, et al.
Pageof 25

Showing results (41-50 of 242) with videos related to

Sort By:
Pageof 25
Mbio|February 26, 2015
Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liverAngela M Mitchell, Amy E L Stone, Linling Cheng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2018
Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistenceRuian Ke, Hui Li, Shuyi Wang, et al.
Plos One|July 16, 2020
Assessing routes of hepatitis C transmission in HIV-infected men who have sex with men using single genome sequencingHui Li, Kristen M Marks, Andrew H Talal, et al.
Journal of Molecular Biology|July 16, 2008
Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoproteinFrançois Stricher, Chih-chin Huang, Anne Descours, et al.
Journal of Virology|April 6, 2007
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donorsAmandeep K Dhillon, Helen Donners, Ralph Pantophlet, et al.
Journal of Virology|March 8, 2013
Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stockMichael Lopker, Juliet Easlick, Sarah Sterrett, et al.
Immunity|January 3, 2024
Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infectionNicole Frumento, Ariadne Sinnis-Bourozikas, Harry T Paul, et al.
Journal of Virology|July 26, 2022
Correction for Rudicell et al., "High Prevalence of Simian Immunodeficiency Virus Infection in a Community of Savanna Chimpanzees"Rebecca S Rudicell, Alex K Piel, Fiona Stewart, et al.
Journal of Virology|November 21, 2008
Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasmaKatie L Davis, Frederic Bibollet-Ruche, Hui Li, et al.
Nature Medicine|February 1, 2002
Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cellsGang Meng, Xiping Wei, Xiaoyun Wu, et al.
Pageof 25